$REGN
REGENERON PHARMACEUTICALS, INC.

2021 Q3 Form 10-Q Financial Statement

#000180422021000033 Filed on November 04, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q4 2020 Q3
Revenue $3.453B $2.423B $2.294B
YoY Change 50.51% 30.02% 31.56%
Cost Of Revenue $453.2M $353.1M $274.0M
YoY Change 65.4% 57.7% 21.51%
Gross Profit $3.000B $2.070B $2.020B
YoY Change 48.5% 6.38% 33.05%
Gross Profit Margin 86.87% 85.43% 88.06%
Selling, General & Admin $445.0M $303.5M $326.9M
YoY Change 36.13% -48.28% 7.39%
% of Gross Profit 14.84% 14.66% 16.18%
Research & Development $665.4M $744.5M $684.6M
YoY Change -2.8% 8.99% 30.15%
% of Gross Profit 22.18% 35.97% 33.89%
Depreciation & Amortization $73.20M $61.70M $59.30M
YoY Change 23.44% 13.63% 12.1%
% of Gross Profit 2.44% 2.98% 2.94%
Operating Expenses $1.110B $902.8M $1.012B
YoY Change 9.78% -28.91% 21.81%
Operating Profit $1.847B $1.167B $1.053B
YoY Change 75.41% 72.71% 42.6%
Interest Expense $14.20M $47.40M $26.30M
YoY Change -46.01% -10.9% 237.18%
% of Operating Profit 0.77% 4.06% 2.5%
Other Income/Expense, Net -$30.60M $10.20M -$54.80M
YoY Change -44.16% -93.66% -282.67%
Pretax Income $1.817B $1.225B $998.3M
YoY Change 81.97% 37.63% 29.9%
Income Tax $184.4M $75.40M $156.2M
% Of Pretax Income 10.15% 6.16% 15.65%
Net Earnings $1.632B $1.149B $842.1M
YoY Change 93.82% 45.1% 25.76%
Net Earnings / Revenue 47.27% 47.43% 36.71%
Basic Earnings Per Share $15.37 $10.90 $7.98
Diluted Earnings Per Share $14.33 $10.24 $7.39
COMMON SHARES
Basic Shares Outstanding 106.2M shares 105.5M shares
Diluted Shares Outstanding 113.9M shares 113.9M shares

Balance Sheet

Concept 2021 Q3 2020 Q4 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.788B $3.587B $3.026B
YoY Change 91.26% 11.61% 5.14%
Cash & Equivalents $3.432B $2.194B $1.573B
Short-Term Investments $2.355B $1.393B $1.453B
Other Short-Term Assets $482.0M $592.0M $785.0M
YoY Change -38.6% -24.87% 19.12%
Inventory $2.054B $1.917B $1.802B
Prepaid Expenses
Receivables $5.452B $4.115B $3.093B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $13.78B $9.779B $9.098B
YoY Change 51.42% 27.18% 27.97%
LONG-TERM ASSETS
Property, Plant & Equipment $3.396B $3.222B $3.138B
YoY Change 8.2% 11.46% 13.24%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $5.671B $3.195B $2.936B
YoY Change 93.16% -3.53% -5.69%
Other Assets $145.9M $168.1M $168.8M
YoY Change -13.57% 16.17% 22.41%
Total Long-Term Assets $9.896B $7.384B $6.986B
YoY Change 41.65% 3.77% 2.29%
TOTAL ASSETS
Total Short-Term Assets $13.78B $9.779B $9.098B
Total Long-Term Assets $9.896B $7.384B $6.986B
Total Assets $23.67B $17.16B $16.08B
YoY Change 47.17% 15.93% 15.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $427.0M $475.5M $443.0M
YoY Change -3.61% 13.73% 31.85%
Accrued Expenses $2.061B $1.522B $1.303B
YoY Change 58.17% 40.02% 58.71%
Deferred Revenue $507.8M $577.7M
YoY Change -2.37%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $719.0M
YoY Change
Total Short-Term Liabilities $3.715B $2.697B $2.338B
YoY Change 58.9% 28.66% 32.42%
LONG-TERM LIABILITIES
Long-Term Debt $1.980B $1.979B $1.978B
YoY Change 0.07% 177.46%
Other Long-Term Liabilities $662.6M $687.1M $454.0M
YoY Change 45.95% 116.27% 66.3%
Total Long-Term Liabilities $2.642B $2.666B $2.432B
YoY Change 8.63% 739.03% 790.95%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.715B $2.697B $2.338B
Total Long-Term Liabilities $2.642B $2.666B $2.432B
Total Liabilities $6.414B $6.138B $5.959B
YoY Change 7.64% 65.2% 73.47%
SHAREHOLDERS EQUITY
Retained Earnings $16.74B $10.89B $9.744B
YoY Change 71.79% 47.61% 47.91%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $7.410B $6.613B $6.242B
YoY Change 18.72% 793.81% 1178.05%
Treasury Stock Shares 17.93M shares 16.43M shares 15.74M shares
Shareholders Equity $17.26B $11.03B $10.13B
YoY Change
Total Liabilities & Shareholders Equity $23.67B $17.16B $16.08B
YoY Change 47.17% 15.93% 15.39%

Cashflow Statement

Concept 2021 Q3 2020 Q4 2020 Q3
OPERATING ACTIVITIES
Net Income $1.632B $1.149B $842.1M
YoY Change 93.82% 45.1% 25.76%
Depreciation, Depletion And Amortization $73.20M $61.70M $59.30M
YoY Change 23.44% 13.63% 12.1%
Cash From Operating Activities $3.414B $1.231B -$254.3M
YoY Change -1442.35% 56.34% -145.63%
INVESTING ACTIVITIES
Capital Expenditures -$133.2M -$161.4M -$153.2M
YoY Change -13.05% 16.12% 25.88%
Acquisitions
YoY Change
Other Investing Activities -$2.306B -$143.6M -$622.6M
YoY Change 270.32% 106.03% 629.89%
Cash From Investing Activities -$2.439B -$305.0M -$775.8M
YoY Change 214.36% 46.14% 274.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 385.4M -305.3M 612.0M
YoY Change -37.03% -11.69% -5663.64%
NET CHANGE
Cash From Operating Activities 3.414B 1.231B -254.3M
Cash From Investing Activities -2.439B -305.0M -775.8M
Cash From Financing Activities 385.4M -305.3M 612.0M
Net Change In Cash 1.360B 620.7M -418.1M
YoY Change -425.33% 166.39% -223.22%
FREE CASH FLOW
Cash From Operating Activities $3.414B $1.231B -$254.3M
Capital Expenditures -$133.2M -$161.4M -$153.2M
Free Cash Flow $3.547B $1.392B -$101.1M
YoY Change -3608.21% 50.3% -114.89%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000872589
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-19034
dei Entity Registrant Name
EntityRegistrantName
REGENERON PHARMACEUTICALS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3444607
dei Entity Address Address Line1
EntityAddressAddressLine1
777 Old Saw Mill River Road
dei Entity Address City Or Town
EntityAddressCityOrTown
Tarrytown
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10591-6707
dei City Area Code
CityAreaCode
914
dei Local Phone Number
LocalPhoneNumber
847-7000
dei Security12b Title
Security12bTitle
Common Stock - par value $.001 per share
dei Trading Symbol
TradingSymbol
REGN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3432400000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2193700000 USD
CY2021Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
2355200000 USD
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1393300000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5452000000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4114700000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
2053800000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
1916600000 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
482000000.0 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
160800000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
13775400000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
9779100000 USD
CY2021Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
5631300000 USD
CY2020Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
3135600000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3395700000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3221600000 USD
CY2021Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
723200000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
858900000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
145900000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
168100000 USD
CY2021Q3 us-gaap Assets
Assets
23671500000 USD
CY2020Q4 us-gaap Assets
Assets
17163300000 USD
CY2021Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
427000000.0 USD
CY2020Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
475500000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
11977000000 USD
CY2021Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
2061000000 USD
CY2020Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1644200000 USD
CY2021Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
719000000.0 USD
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
0 USD
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
507800000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
577700000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3714800000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2697400000 USD
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1979600000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1978500000 USD
CY2021Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
0 USD
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
717200000 USD
CY2021Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
56500000 USD
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
57800000 USD
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
662600000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
687100000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
16739300000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
10893000000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
9500000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
6413500000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
6138000000 USD
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7919300000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6716200000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
29300000 USD
CY2021Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
17930390 shares
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
16431520 shares
CY2021Q3 us-gaap Treasury Stock Value
TreasuryStockValue
7410200000 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
6613300000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
17258000000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
11025300000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23671500000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17163300000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3452800000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2294000000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11120000000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6074200000 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
665400000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
684600000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2122500000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1990500000 USD
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
445000000.0 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
326900000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1265300000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1042500000 USD
CY2021Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-42000000.0 USD
CY2020Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
44600000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
29800000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
135200000 USD
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
1605600000 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
1240900000 USD
us-gaap Costs And Expenses
CostsAndExpenses
4812900000 USD
us-gaap Costs And Expenses
CostsAndExpenses
3664600000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1847200000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1053100000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
6307100000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
2409600000 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-16400000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-28500000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
558500000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
218300000 USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
14200000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
26300000 USD
us-gaap Interest Expense
InterestExpense
43200000 USD
us-gaap Interest Expense
InterestExpense
42100000 USD
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-30600000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-54800000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
515300000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
176200000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1816600000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
998300000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6822400000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2585800000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
184400000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
156200000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
976100000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
221800000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
1632200000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
842100000 USD
us-gaap Net Income Loss
NetIncomeLoss
5846300000 USD
us-gaap Net Income Loss
NetIncomeLoss
2364000000 USD
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
15.37
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
7.98
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
55.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
21.83
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
14.33
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.39
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
52.29
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
20.36
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
106200000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105500000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105500000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
108300000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
113900000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
113900000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
111800000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
116100000 shares
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
1632200000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
842100000 USD
us-gaap Net Income Loss
NetIncomeLoss
5846300000 USD
us-gaap Net Income Loss
NetIncomeLoss
2364000000 USD
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-6400000 USD
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4900000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-20500000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
10900000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
200000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
200000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
700000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-1200000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1626000000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
837400000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5826500000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2373700000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
11025300000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
93900000 USD
CY2021Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
66400000 USD
CY2021Q1 regn Stock Issued Distributed During Period Value Employee Benefit Plan
StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan
10000000.0 USD
CY2021Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
323500000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
135600000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
1115200000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-13100000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
216600000 USD
CY2021Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
26100000 USD
CY2021Q2 regn Stock Issued Distributed During Period Value Employee Benefit Plan
StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan
14100000 USD
CY2021Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
288600000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
135900000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
3098900000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-500000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
15127300000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
816500000 USD
CY2021Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
269600000 USD
CY2021Q3 regn Stock Issued Distributed During Period Value Employee Benefit Plan
StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan
12000000.0 USD
CY2021Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
190600000 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
136400000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
1632200000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-6200000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
17258000000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
11089700000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
817400000 USD
CY2020Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
155100000 USD
CY2020Q1 regn Stock Issued Distributed During Period Value Employee Benefit Plan
StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan
14600000 USD
CY2020Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
336000000.0 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
108000000.0 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
624600000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-30200000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
12133000000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1355500000 USD
CY2020Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
416500000 USD
CY2020Q2 regn Stock Issued Distributed During Period Value Employee Benefit Plan
StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan
10100000 USD
CY2020Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
5071800000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
105200000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
897300000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
44600000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
9057400000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
297500000 USD
CY2020Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
80900000 USD
CY2020Q3 regn Stock Issued Distributed During Period Value Employee Benefit Plan
StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan
9900000 USD
CY2020Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
100400000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
104600000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
842100000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4700000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
10125500000 USD
us-gaap Net Income Loss
NetIncomeLoss
5846300000 USD
us-gaap Net Income Loss
NetIncomeLoss
2364000000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
211700000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
174200000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
413300000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
310500000 USD
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
524600000 USD
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
162300000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-264400000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-51000000.0 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-58800000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-117900000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1342900000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1275300000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
330600000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
402400000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
316800000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-16400000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-71200000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
112300000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
500400000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
80800000 USD
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-1137500000 USD
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-976900000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4708800000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1387100000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
4872300000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
2642700000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
1897300000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
3330300000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
397000000.0 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
453200000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3372000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
234400000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1129600000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2471100000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
450300000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
652500000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
778500000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5465700000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1981900000 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
1500000000 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
1500000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-99200000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1665200000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1237600000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-43700000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2207300000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1630300000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3444900000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1586600000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
1632200000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
842100000 USD
us-gaap Net Income Loss
NetIncomeLoss
5846300000 USD
us-gaap Net Income Loss
NetIncomeLoss
2364000000 USD
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
106200000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105500000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105500000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
108300000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
113900000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
113900000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
111800000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
116100000 shares
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
15.37
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
7.98
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
55.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
21.83
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
14.33
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.39
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
52.29
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
20.36
CY2021Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
6600900000 USD
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
21000000.0 USD
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
7000000.0 USD
CY2021Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
6614900000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
3649200000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
40100000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
200000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3689100000 USD
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
2355200000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1393300000 USD
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
4259700000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
2295800000 USD
CY2021Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
6614900000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3689100000 USD
CY2021Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
2932900000 USD
CY2021Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
7000000.0 USD
CY2021Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
0 USD
CY2021Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0 USD
CY2021Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
2932900000 USD
CY2021Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
7000000.0 USD
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 USD
CY2021Q3 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 USD
CY2020Q3 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 USD
regn Marketable Securities Realized Gain
MarketableSecuritiesRealizedGain
28500000 USD
regn Marketable Securities Realized Loss
MarketableSecuritiesRealizedLoss
0 USD
CY2021Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-29100000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
523800000 USD
CY2020Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-37500000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
133800000 USD
CY2021Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
40000000 USD
CY2020Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
59200000 USD
CY2021Q3 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
1891000000 USD
CY2020Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
1958000000 USD
CY2021Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
646300000 USD
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
459400000 USD
CY2021Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
843700000 USD
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
904600000 USD
CY2021Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
60100000 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
121700000 USD
CY2021Q3 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
503700000 USD
CY2020Q4 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
430900000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
2053800000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
1916600000 USD
CY2021Q3 us-gaap Inventory Write Down
InventoryWriteDown
38700000 USD
us-gaap Inventory Write Down
InventoryWriteDown
188000000 USD
CY2020Q3 us-gaap Inventory Write Down
InventoryWriteDown
11800000 USD
us-gaap Inventory Write Down
InventoryWriteDown
23600000 USD
CY2020Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
200000 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1600000 shares
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.102
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.156
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.143
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.086
CY2021Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
300000 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
900000 shares
CY2021Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
190500000 USD
CY2020Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
100400000 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
802700000 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
373300000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3432400000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1573000000 USD
CY2021Q3 us-gaap Restricted Cash
RestrictedCash
12500000 USD
CY2020Q3 us-gaap Restricted Cash
RestrictedCash
13600000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3444900000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1586600000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
70100000 USD
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
83600000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
100400000 USD
CY2019 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
133700000 USD

Files In Submission

Name View Source Status
0001804220-21-000033-index-headers.html Edgar Link pending
0001804220-21-000033-index.html Edgar Link pending
0001804220-21-000033.txt Edgar Link pending
0001804220-21-000033-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image_1a.jpg Edgar Link pending
image_2a.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
regen-ex_101x9302021x10q.htm Edgar Link pending
regen-ex_102x9302021x10q.htm Edgar Link pending
regn-20210930.htm Edgar Link pending
regn-20210930.xsd Edgar Link pending
regn-20210930_cal.xml Edgar Link unprocessable
regn-20210930_def.xml Edgar Link unprocessable
regn-20210930_htm.xml Edgar Link completed
regn-20210930_lab.xml Edgar Link unprocessable
regn-20210930_pre.xml Edgar Link unprocessable
regn-ex_311x09302021x10q.htm Edgar Link pending
regn-ex_312x09302021x10q.htm Edgar Link pending
regn-ex_32x09302021x10q.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending